ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,404Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 252

$635K Total Retail Price of All Prescriptions

Rank: 66 out of 252

503 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 9,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 556 518 1 1
SIMVASTATIN 441 384 2 2
AMLODIPINE BESYLATE 418 377 3 4
LISINOPRIL 341 297 4 3
OMEPRAZOLE 281 228 5 6
POTASSIUM CHLORIDE 239 211 6 8
ATENOLOL 237 206 7 18
FUROSEMIDE 228 173 8 7
METFORMIN HCL ER 221 198 9 74
AZITHROMYCIN 216 176 10 37
HYDROCHLOROTHIAZIDE 214 177 11 13
GLIMEPIRIDE 204 182 12 40
ZOLPIDEM TARTRATE 199 145 13 21
CRESTOR 191 143 14 34
METOPROLOL SUCCINATE 169 156 15 19
ATORVASTATIN CALCIUM 156 144 16 16
TRIAMTERENE-HCTZ 148 134 17 33
MELOXICAM 148 133 17 20
GABAPENTIN 146 118 19 11
CITALOPRAM HBR 141 136 20 15
CEFUROXIME 139 109 21 114
LOSARTAN POTASSIUM 137 117 22 24
WARFARIN SODIUM 127 104 23 14
NEXIUM 123 87 24 23
DONEPEZIL HCL 119 105 25 28
HYDROCODONE-ACETAMINOPHEN 119 88 S3 25 5
FENOFIBRATE 116 107 27 64
METFORMIN HCL 114 112 28 9
PRAVASTATIN SODIUM 113 99 29 12
METRONIDAZOLE 106 79 30 240
SERTRALINE HCL 96 89 31 27
CLONIDINE HCL 94 92 32 35
TRIAMTERENE-HYDROCHLOROTHIAZID 93 61 33 134
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 67 34 25
TAMSULOSIN HCL 85 81 34 26
ALLOPURINOL 80 53 36 30
TRAMADOL HCL 77 61 37 17
CLOPIDOGREL 75 60 38 29
SINGULAIR 71 36 39 100
VERAPAMIL ER 69 64 40 83
PANTOPRAZOLE SODIUM 67 46 41 62
CYMBALTA 66 42 42 45
METOPROLOL TARTRATE 66 49 42 10
ESTRADIOL 64 51 R 44 76
PREDNISONE 60 45 45 42
NIFEDIPINE ER 60 60 45 108
NAMENDA 59 59 47 41
ALENDRONATE SODIUM 59 59 47 32
ROPINIROLE HCL 59 49 47 84
DOXYCYCLINE HYCLATE 58 45 50 92
PREMARIN 57 46 R 51 116
PLAVIX 53 46 52 43
JANUVIA 51 30 53 88
PROMETHAZINE HCL 51 42 R 53 85
DIGOXIN 51 39 53 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.